Product Details
Place of Origin: ANHUI
Brand Name: BBCA
Certification: GMP
Model Number: 25MG
Payment & Shipping Terms
Minimum Order Quantity: 1000000 Tablets
Delivery Time: 30 Working days
Payment Terms: L/C, T/T
Supply Ability: 100 Million Tablets
Model: |
25MG |
Name: |
Pharmaceutical Tablets |
Type: |
Cardiovascular Naftopidil Tablets |
Certification: |
GMP |
Origin: |
ANHUI |
Brand: |
BBCA |
Model: |
25MG |
Name: |
Pharmaceutical Tablets |
Type: |
Cardiovascular Naftopidil Tablets |
Certification: |
GMP |
Origin: |
ANHUI |
Brand: |
BBCA |
Pharmaceutical Tablets Cardiovascular Naftopidil Tablets
[INDICATIONS]
It is used to relieve the symptoms of urinary obstruction caused by benign prostatic hyperplasia (BPH).
[USAGE AND DOSAGE]
Oral. Usually, the initial dosage of adult is 25mg (1 tablets), once a day, taken before bedtime. The dose can be adjusted appropriately with the clinical effect. The maximum dose may not exceed 75mg (3 tablets) per day. Elderly patients should start from low dose (12.5mg/day), and care for them.
[ADVERSE REACTION]
dizziness, standing vertigo, head weight, headache, tinnitus, constipation, stomach discomfort, edema, chills, AST elevation and ALT elevation.
[CONTRAINDICATION]
It is forbidden for someone has a history of allergy .
[DRUG INTERACTION]
This product has synergistic antihypertensive effect with the combination of diuretics and antihypertensive drugs, and should be reduced when combined.
[DRUG OVERDOSE]
There are no reports of overdose of the drug at present. If you take too much, you should take symptomatic treatment.
